64321-24-0

Basic information

• Product Name: 2-Amino-6-chloronicotinamide
• Synonyms: 2-Amino-6-chloronicotinamide;2-AMino-6-chloropyridine-3-carboxaMide;3-PyridinecarboxaMide, 2-aMino-6-chloro-;2-Amino-6-chloro-3-pyridinecarboxamide
• CAS NO: 64321-24-0
• Molecular Formula: C₆H₆ClN₃O
• Molecular Weight: 171.586
• Mol File: 64321-24-0.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 334.805 °C at 760 mmHg
• Flash Point: 156.285 °C
• Appearance: /
• Density: 1.484
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.655
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 14.31±0.50(Predicted)
• CAS DataBase Reference: 2-Amino-6-chloronicotinamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino-6-chloronicotinamide(64321-24-0)
• EPA Substance Registry System: 2-Amino-6-chloronicotinamide(64321-24-0)

Safety Data

• Hazardous Substances Data: 64321-24-0(Hazardous Substances Data)

Usage

General Description

2-Amino-6-chloronicotinamide is an organic compound and a derivative of nicotinamide. It is a white to pale yellow crystalline solid with a molecular formula C6H6ClN3O and a molar mass of 167.58 g/mol. This chemical is used in the production of pharmaceuticals and agrochemicals, and it also exhibits potential antineoplastic and antiviral activities. It is classified as a mildly hazardous chemical and proper safety precautions should be taken when handling and storing it. Additionally, 2-Amino-6-chloronicotinamide is known to be a potential mutagen, so it should be handled with care to minimize exposure to humans and the environment.

InChI:InChI=1/C6H6ClN3O/c7-4-2-1-3(6(9)11)5(8)10-4/h1-2H,(H2,8,10)(H2,9,11)

Upstream product

• 58584-92-2 2-amino-6-chloronicotinic acid 
• 38496-18-3 2,6-dichloropyridine-3-carboxylic acid 

Downstream Products

• 552331-43-8 7-chloro-pyrido[2,3-d]pyrimidin-4-ol 
• 938443-19-7 7-chloropyrido[2,3-d]pyrimidine-2,4-diol 
• 938440-64-3 KU-63794 
• 1009302-61-7 C₂₄H₂₉N₅O₄ 
• 1009302-80-0 C₂₅H₃₂N₆O₃ 
• 1009302-46-8 C₂₄H₃₁N₅O₄ 
• 1009302-47-9 C₂₃H₂₄N₆O₃ 
• 1009298-09-2 AZD₈₀₅₅ 
• 938443-20-0 2,4,7-trichloropyrido[2,3-d]pyrimidine 
• 938443-21-1 4-(2,7-dichloropyrido[2,3-d]pyrimidin-4-yl)morpholine 
• 938443-23-3 7-chloro-2-((2S,6R)-2,6-dimethyl-morpholin-4-yl)-4-morpholin-4-yl-pyrido[2,3-d]pyrimidine 
• 938443-29-9 7-(3-chloromethyl-4-methoxy-phenyl)-2-((2S,6R)-2,6-dimethyl-morpholin-4-yl)-4-morpholin-4-yl-pyrido[2,3-d]pyrimidine 
• 1424432-35-8 C₂₆H₃₄N₆O₃ 
• 1424432-36-9 C₂₅H₃₂N₆O₂ 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS MTOR INHIBITORS

The present disclosure describes novel heterocyclic mTOR inhibitors and methods for preparing them. The pharmaceutical compositions comprising such mTOR inhibitors and methods of using them for treating cancer, infectious diseases, and other mTOR associated disorders are also described.

PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, R6, R7, G1 and G2, are defined herein.

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. (I)